Single-center experience with first-line S-1 plus cisplatin chemotherapy for locally advanced unresectable and metastatic gastric and gastroesophageal junction adenocarcinoma in a Caucasian population
Latest Information Update: 07 Oct 2015
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 07 Oct 2015 New trial record